These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 37098372)
1. Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice. Zhang Y; Wang S; Dai X; Liu T; Liu Y; Shi H; Yin J; Xu T; Zhang Y; Zhao D; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D J Ethnopharmacol; 2023 Aug; 312():116530. PubMed ID: 37098372 [TBL] [Abstract][Full Text] [Related]
2. Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice. Lu M; Yin J; Xu T; Dai X; Liu T; Zhang Y; Wang S; Liu Y; Shi H; Zhang Y; Mo F; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D J Ethnopharmacol; 2024 Jan; 319(Pt 2):117262. PubMed ID: 37788785 [TBL] [Abstract][Full Text] [Related]
3. 9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice. Wu X; Huang R; Ai G; Chen H; Ma X; Zhang J; Huang Q; Lao J; Zeng H; Li C; Xie J; Li Y; Su Z; Chen J; Huang X J Ethnopharmacol; 2024 Dec; 335():118606. PubMed ID: 39038504 [TBL] [Abstract][Full Text] [Related]
4. Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis. Ai G; Huang R; Xie J; Zhong L; Wu X; Qin Z; Su Z; Chen J; Yang X; Dou Y J Ethnopharmacol; 2023 Jan; 301():115775. PubMed ID: 36198377 [TBL] [Abstract][Full Text] [Related]
5. Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Liu T; Gao H; Zhang Y; Wang S; Lu M; Dai X; Liu Y; Shi H; Xu T; Yin J; Gao S; Wang L; Zhang D Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422572 [TBL] [Abstract][Full Text] [Related]
6. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway. Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754 [TBL] [Abstract][Full Text] [Related]
7. Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model. Li Q; Huang Z; Liu D; Zheng J; Xie J; Chen J; Zeng H; Su Z; Li Y Drug Des Devel Ther; 2021; 15():3241-3254. PubMed ID: 34349501 [TBL] [Abstract][Full Text] [Related]
8. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout. de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138 [TBL] [Abstract][Full Text] [Related]
9. Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice. Wang M; Zhao J; Zhang N; Chen J Biomed Pharmacother; 2016 Oct; 83():975-988. PubMed ID: 27522260 [TBL] [Abstract][Full Text] [Related]
10. Phloretin ameliorates hyperuricemia-induced chronic renal dysfunction through inhibiting NLRP3 inflammasome and uric acid reabsorption. Cui D; Liu S; Tang M; Lu Y; Zhao M; Mao R; Wang C; Yuan Y; Li L; Chen Y; Cheng J; Lu Y; Liu J Phytomedicine; 2020 Jan; 66():153111. PubMed ID: 31790902 [TBL] [Abstract][Full Text] [Related]
11. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice. Yang Y; Zhang DM; Liu JH; Hu LS; Xue QC; Ding XQ; Kong LD J Ethnopharmacol; 2015 Jul; 169():49-59. PubMed ID: 25914040 [TBL] [Abstract][Full Text] [Related]
12. The impact of chrysanthemi indici flos-enriched flavonoid part on the model of hyperuricemia based on inhibiting synthesis and promoting excretion of uric acid. Jiao L; Wang R; Dong Y; Su J; Yu J; Yan M; Chen S; Lv G J Ethnopharmacol; 2024 Oct; 333():118488. PubMed ID: 38925319 [TBL] [Abstract][Full Text] [Related]
13. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice. Wang R; Ma CH; Zhou F; Kong LD Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200 [TBL] [Abstract][Full Text] [Related]
14. The Extract of Wu YL; Chen JF; Jiang LY; Wu XL; Liu YH; Gao CJ; Wu Y; Yi XQ; Su ZR; Cai J; Chen JN Front Pharmacol; 2021; 12():698219. PubMed ID: 34483901 [No Abstract] [Full Text] [Related]
15. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats. Hu QH; Zhang X; Pan Y; Li YC; Kong LD Biochem Pharmacol; 2012 Jul; 84(1):113-25. PubMed ID: 22426011 [TBL] [Abstract][Full Text] [Related]
16. Chen J; Xu L; Jiang L; Wu Y; Wei L; Wu X; Xiao S; Liu Y; Gao C; Cai J; Su Z Food Funct; 2021 Oct; 12(19):9416-9431. PubMed ID: 34606558 [No Abstract] [Full Text] [Related]
17. Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in high fructose-fed rats. Ma CH; Kang LL; Ren HM; Zhang DM; Kong LD J Ethnopharmacol; 2015 Aug; 172():108-17. PubMed ID: 26117533 [TBL] [Abstract][Full Text] [Related]
18. Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis. Zhou X; Zhang B; Zhao X; Lin Y; Wang J; Wang X; Hu N; Wang S Food Funct; 2021 Jun; 12(12):5637-5649. PubMed ID: 34018499 [TBL] [Abstract][Full Text] [Related]
19. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling. Ren Q; Tao S; Guo F; Wang B; Yang L; Ma L; Fu P Phytomedicine; 2021 Jul; 87():153552. PubMed ID: 33994251 [TBL] [Abstract][Full Text] [Related]
20. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats. Chen X; Ge HZ; Lei SS; Jiang ZT; Su J; He X; Zheng X; Wang HY; Yu QX; Li B; Lv GY; Chen SH Biomed Pharmacother; 2020 Dec; 132():110765. PubMed ID: 33120237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]